While it may execute its neuroprotective function by inhibiting the expression of MMP9 in AD (Erb et al., 2015), increased P2RY14 expression was observed in rat primary LPS-mediated microglial activation (Bianco et al., 2005), correlating with neuroinflammation. Here, P2RY14 is linked to Alzheimer disease.